PFE

Pfizer Inc

Feb 06 • 12:04PM ET

27.17

+0.68 2.59 %

Healthcare • Drug Manufacturers - General • USA • NYSE

Today, 6:50 AMPfizer says the FDA has accepted and granted Priority Review to its sBLA for HYMPAVZI (marstacimab) to expand hemophilia A and B use to younger patients and those with inhibitors, with a Q2 2026 PDUFA date, and launches the TrumpRx cost savings program to lower prescription costs for millions of Americans.

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN-D

| Held by: VTI VOO IVV SPY VTV XLV VYM VHT DVY FDL

Scroll to Statements

Index	S&P 500	P/E	20.05	EPS (ttm)	1.36	Insider Own	0.09%	Shs Outstand	5.69B	Perf Week	2.78%
Market Cap	154.51B	Forward P/E	9.58	EPS next Y	2.84	Insider Trans	0.00%	Shs Float	5.68B	Perf Month	7.50%
Enterprise Value	201.53B	PEG	-	EPS next Q	0.73	Inst Own	66.95%	Short Float	2.29%	Perf Quarter	10.42%
Income	7.75B	P/S	2.47	EPS this Y	-7.77%	Inst Trans	-0.36%	Short Ratio	2.19	Perf Half Y	12.15%
Sales	62.58B	P/B	1.67	EPS next Y	-4.44%	ROA	4.58%	Short Interest	129.80M	Perf YTD	9.14%
Book/sh	16.32	P/C	10.31	EPS next 5Y	-8.62%	ROE	10.59%	52W High	27.69 -1.86%	Perf Year	2.78%
Cash/sh	2.64	P/FCF	14.89	EPS past 3/5Y	-37.12% -3.51%	ROIC	5.16%	52W Low	20.92 29.93%	Perf 3Y	-38.20%
Dividend Est.	1.76 (6.46%)	EV/EBITDA	7.71	Sales past 3/5Y	-14.56% 8.48%	Gross Margin	76.10%	Volatility	2.78% 2.18%	Perf 5Y	-24.09%
Dividend TTM	1.72 (6.33%)	EV/Sales	3.22	EPS Y/Y TTM	-3.74%	Oper. Margin	27.83%	ATR (14)	0.65	Perf 10Y	-5.95%
Dividend Ex-Date	Jan 23, 2026	Quick Ratio	0.97	Sales Y/Y TTM	-1.65%	Profit Margin	12.38%	RSI (14)	61.77	Recom	2.39
Dividend Gr. 3/5Y	2.23% 2.37%	Current Ratio	1.28	EPS Q/Q	-509.90%	SMA20	4.55%	Beta	0.44	Target Price	28.66
Payout	126.47%	Debt/Eq	0.66	Sales Q/Q	-1.16%	SMA50	5.99%	Rel Volume	0.78	Prev Close	26.49
Employees	81000	LT Debt/Eq	0.62	Earnings	Feb 03 BMO	SMA200	9.90%	Avg Volume	59.27M	Price	27.17
IPO	Jan 17, 1944	Option/Short	Yes / Yes	EPS/Sales Surpr.	16.42% 4.20%	Trades		Volume	19,714,824	Change	2.59%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-07-26	Resumed	UBS	Neutral	$25
Dec-02-25	Resumed	Citigroup	Neutral	$26
Nov-13-25	Initiated	Scotiabank	Sector Outperform	$30
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51

Show Previous Ratings

Today 11:06AM	Pfizer Bets Big on Obesity and Oncology With 2026 Pipeline Push (Zacks)
08:00AM	China Biotech Lights Up. U.S. Stocks Prepare For A New Powerhouse. (Investor's Business Daily)
07:45AM	5 High-Yield Stocks (6%-8%) Every Retiree Should Consider Now (24/7 Wall St.)
06:45AM	FDA Grants Priority Review for HYMPAVZI (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need (Business Wire)
12:13AM	Trump Says People Will 'Save A Lot Of Money And Be Healthy' With Launch Of TrumpRx Website - But Will It Actually Fill Prescriptions? (Benzinga)
09:17PM	Loading…
Feb-05-26 09:17PM	Trump launches TrumpRX website offering discounted prescription drugs (Investing.com)
08:06PM	Adaptive Biotechnologies Q4 Earnings Call Highlights (MarketBeat)
07:09PM	Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans (Business Wire)
05:22PM	Pfizer Pops on Q4 Results-But This May Be the Catalyst That Matters Most (MarketBeat)
04:17PM	TrumpRx's launch is hours away. Here's why it may not lower drug prices for most Americans. (MarketWatch)
01:29PM	Bristol Myers Earnings Reveal Struggling Legacy Drug Business. Why the Stock Is Rising. (Barrons.com)
10:49AM	Bristol-Myers Stock Up as Q4 Earnings and Revenues Beat Estimates (Zacks)
09:55AM	This Medical Technology Leader Sees Growth Into The 2040s (Investor's Business Daily)
08:21AM	The Week Ahead: Inflation Data Hits Amid Earnings Season (Schaeffer's Research)
07:58AM	Rapid Innovation is Reshaping Oncology: Stocks in Focus (Zacks)
03:00AM	Loading…
03:00AM	Big Pharma CEOs set sights on massive growth in years to come (Pharma Voice)
Feb-04-26 09:35PM	Pfizer Inc. (PFE): A Bull Case Theory (Insider Monkey)
01:11PM	Pfizer (PFE) Announces Positive Phase 2b Results for Obesity Drug Showing 12.30% Weight Loss (Insider Monkey)
11:40AM	Eli Lilly Soared by 39% in 2025, but Here's Another Healthcare Stock to Buy in 2026 (Motley Fool)
08:45AM	Novo Nordisk: Pfizer weight loss drug offers credible new competition (Proactive)
04:51AM	Earnings roundup: Amgen vs. FDA, Pfizers defense and Mercks $70B-in-sales plan (BioPharma Dive)
01:08AM	Pfizer Q4 Earnings Call Highlights (MarketBeat)
12:32AM	PFE Q4 CY2025 Deep Dive: Obesity Pipeline and Cost Discipline Face Post-COVID Headwinds (StockStory)
Feb-03-26 11:35PM	Will the Market Crash in 2026? Here's What History Says and What to Do About It (Motley Fool)
11:09PM	Asian shares gained and gold and silver climb higher after a retreat on Wall St (Associated Press Finance)
09:49PM	Why 2026 Could Be the Year Pfizer's Stock Finally Takes Off (Motley Fool)
06:03PM	Stocks to Watch Tuesday Recap: PayPal, PepsiCo, AMD, Disney (The Wall Street Journal)
04:36PM	These Stocks Are Todays Movers: Palantir, Pfizer, AMD, PayPal, Novo Nordisk, PepsiCo, Merck, and More (Barrons.com)
04:26PM	Stocks Tumble on AI Disruption Fears (Barchart)
04:03PM	Pfizer Inc (PFE) Q4 2025 Earnings Call Highlights: Strategic Acquisitions and Revenue Guidance ... (GuruFocus.com)
03:14PM	Loading…
03:14PM	Analyst Report: Pfizer Inc. (Morningstar Research)
03:05PM	Stocks to Watch Tuesday: PayPal, PepsiCo, AMD, Disney (The Wall Street Journal)
02:57PM	These Are The Worst 25 Stocks to Own in February (Schaeffer's Research)
02:48PM	Obesity Drug Bets Get a Reality Checkbut Investors Shouldnt Panic (The Wall Street Journal)
02:24PM	Stock market today: Dow, Nasdaq, S&P 500 sink as tech falters amid flood of earnings (Yahoo Finance)
02:06PM	Pfizer is at 'the end of the beginning' in entry to GLP-1s: CEO (Yahoo Finance Video)
01:59PM	Pfizer sets sights on R&D strategy amid modest FY25 results (Pharmaceutical Technology)
12:33PM	Stock market today: Nasdaq, S&P 500 slide as investors digest flood of tech earnings, government shutdown (Yahoo Finance)
12:33PM	Stock market today: Dow, Nasdaq, S&P 500 fall as investors digest flood of tech earnings, government shutdown (Yahoo Finance)
12:22PM	Pfizer Releases Early Obesity Data Showing Up to 12.3% Weight Loss (GuruFocus.com)
04:09PM	Pfizer Dives; Why Lilly's Zepbound Still Looks Like The Weight-Loss Heavyweight (Investor's Business Daily)
11:40AM	Pfizer, Merk report Q4 results: Citi's Geoff Meacham on key takeaways (CNBC TV)
11:36AM	Why Pfizer Stock Dropped Today (Motley Fool)
11:32AM	Pfizer Stock Slides Despite Q4 Earnings Beat and New Obesity Drug Data (Zacks)
11:30AM	Why Is Pfizer Stock Sliding Today (GuruFocus.com)
11:04AM	2 Pharma Stocks React to Quarterly Results, Guidance (Schaeffer's Research)
11:00AM	Market Awaits JOLTS Jobs Report (Zacks)
10:48AM	Pfizer shares drop on quarterly loss (AFP)
10:40AM	Pfizer beats quarterly estimates despite Covid product decline, reaffirms modest outlook (CNBC TV)
10:35AM	Pfizer Projects Revenue Dip in 2026 as Patent Losses Weigh (GuruFocus.com)
10:32AM	Pfizer Stock Drops On Obesity-Drug Study Data (The Wall Street Journal)
10:26AM	Q4 Earnings, JOLTS & a Changing of the Disney Guard (Zacks)
09:59AM	Pfizer Targets Monthly Obesity Shot. Why Lilly Could Still Have The Weight-Loss Heavyweight. (Investor's Business Daily)
09:36AM	Stock market today: Nasdaq, S&P 500 fall as investors digest flood of tech earnings, partial government shutdown (Yahoo Finance)
09:36AM	Stock market today: Dow, S&P 500, Nasdaq edge higher as Palantir lifts tech hopes, earnings flood in (Yahoo Finance)
09:30AM	Pfizer (PFE) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates (Zacks)
09:02AM	S&P 500, Nasdaq poised for higher open as earnings deluge takes center stage (Reuters)
08:50AM	Pfizer's Newly Acquired Drug Shows Weight Loss Of Just Around 13%, Stock Drops (Benzinga)
08:19AM	Pharma stocks slump as Pfizer and Merck report earnings (Quartz)
08:19AM	Merck and Pfizer decline vs the broader market as results released (Quartz)
07:55AM	Pfizer (PFE) Q4 Earnings and Revenues Beat Estimates (Zacks)
07:38AM	Pfizer Reaffirms FY26 Outlook As Q4 Results Top Estimates - Update (RTT News)
07:28AM	Pfizer says once-a-month weight-loss drug works as it forecasts profit decline (MarketWatch)
07:24AM	Jim Cramer Expresses Concern About Pfizer Despite Its "Terrific Yield" (Insider Monkey)
07:21AM	Pfizer Sales Fall on Continued Lower Covid-19 Drug Demand (The Wall Street Journal)
07:19AM	Pfizer (NYSE:PFE) Posts Better-Than-Expected Sales In Q4 CY2025 (StockStory)
07:02AM	Pfizer Stock Falls After Solid Earnings. What's Troubling Wall Street. (Barrons.com)
06:53AM	Pfizer: Q4 Earnings Snapshot (Associated Press Finance)
06:45AM	Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance (Business Wire)
06:40AM	Pfizer's Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial (Business Wire)
05:25AM	These Stocks Are Moving the Most Today: Palantir, Teradyne, Tesla, AMD, NXP Semiconductors, and More (Barrons.com)
05:12AM	Goldman Sachs Maintains Neutral on Pfizer (PFE) Amid Rising Margin Pressure (Insider Monkey)
05:00AM	Advanced Micro Devices heads earnings slate (MarketWatch)
04:19AM	Stock Market Today: S&P 500 eyes fresh record as Dow and Nasdaq also called higher; Palantir rises after earnings; gold and silver rebound; AMD results on tap. (MarketWatch)
03:01AM	Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
Feb-02-26 07:00PM	AMD earnings, Netflix-Warner Bros. hearing: What to Watch (Yahoo Finance Video)
06:02PM	Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
02:08PM	Is Novo Nordisk Stock a Bargain Right Now? (Motley Fool)
01:59PM	Sanofi Found In Breach Of UK Pharmaceutical Marketing Code Over Beyfortus Claims (Benzinga)
11:12AM	Market Awaits January Manufacturing Numbers (Zacks)
10:35AM	Six More Weeks of Q4 Earnings Season? (Zacks)
10:25AM	What's in Store for These 5 Pharma Bigwigs This Earnings Season? (Zacks)
08:29AM	Palantir, AMD, Amazon and More Stocks with Earnings This Week (Benzinga)
08:10AM	Should You Buy, Hold, or Sell BMY Stock Ahead of Q4 Earnings? (Zacks)
07:00AM	Option Volatility And Earnings Report For February 2 - 6 (Barchart)
06:52AM	3 Headwinds Facing Pfizer in 2026 (Motley Fool)
06:31AM	How Pfizers CEO wielded moral clarity to help his team do the impossible (Fortune)
06:07AM	Analysis-Obesity market sales potential tightens as Novo and Lilly enter new era (Reuters)
02:13AM	Jobs Report, Big Tech and Pharma Earnings: What to Watch This Week (The Wall Street Journal)
Feb-01-26 10:03PM	Earnings To Watch: Pfizer (PFE) Reports Q4 Results Tomorrow (StockStory)
07:47AM	January jobs data, Alphabet and Amazon earnings, more Warsh fallout: What to watch this week (Yahoo Finance)
06:20AM	Here's Why Pfizer Stock Is Still a Buy (Motley Fool)
Jan-31-26 08:28PM	Passive Income Investors Will Love These Cheap Dividend Stocks (24/7 Wall St.)
07:49AM	Cantor Fitzgerald Raises Pfizer (PFE) PT to $27 Amid Shifting Obesity Data Focus (Insider Monkey)
Jan-30-26 04:57PM	Jobs Report, More Tech Earnings: What to Watch Next Week (The Wall Street Journal)
01:22PM	Well save the world from cancer: Inside Pfizer CEOs $23 billion postCOVID bet on oncology (Fortune)
11:28AM	Regeneron Pharmaceuticals Q4 Earnings Call Highlights (MarketBeat)
10:19AM	$668B Oncology Surge: 5 Platforms Cracking the Code on GI Tumors (PR Newswire)
09:00AM	Investors Heavily Search Pfizer Inc. (PFE): Here is What You Need to Know (Zacks)
08:49AM	Will BMY's Oncology Collaborations Drive Its Next Growth Phase? (Zacks)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dolsten Mikael	Former Officer	May 23 '25	Proposed Sale	23.09	59,781	1,380,632		May 23 10:54 AM
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM
BLAYLOCK RONALD E	Director	Feb 13 '25	Buy	25.65	19,457	499,072	27,707	Feb 14 05:16 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc

Upgrade your FINVIZ experience